Service profile
Alumis
Clinical-stage biopharmaceutical company developing oral small molecule therapies targeting TYK2 and other pathways for treating autoimmune diseases including psoriasis, lupus, and inflammatory bowel disease.
About
What Alumis is
Clinical-stage biopharmaceutical company developing oral small molecule therapies targeting TYK2 and other pathways for treating autoimmune diseases including psoriasis, lupus, and inflammatory bowel disease.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://alumis.com |
| Status coverage | Public status page |
| Founded | 2019 |
| Headquarters | South San Francisco, California, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...